Clustering data with hclust algorithm for (Study ST003603)
(Analysis AN005919)| Metabolite | Structure | F1 | F2 | F3 | F4 | F5 | F6 | F7 | F8 | F9 |
|---|---|---|---|---|---|---|---|---|---|---|
| a-Linolenic acid (Octadecatrienoic acid) | ME934357 | 1.65 | 1.37 | 0.96 | 0.69 | 1.21 | 0.54 | 0.88 | 0.61 | 0.97 |
| 3^,5^-Cyclic IMP | ME934301 | 1.07 | 1.13 | 0.92 | 1.02 | 0.66 | 1.01 | 0.97 | 1.04 | 1.18 |
| ADP 13C1 | ME934376 | NA | 1.14 | NA | 1.11 | NA | 1.02 | NA | 0.89 | 0.85 |
| 1-4-beta-D-Xylan | ME934337 | 1.07 | 1.58 | 0.83 | 0.28 | 1.14 | 2.15 | 1.22 | 0.65 | 0.09 |
| AMP | ME934292 | 0.89 | 1.13 | 0.82 | 0.49 | 0.56 | 2.01 | 0.90 | 1.58 | 0.62 |
| ADP | ME934291 | 0.68 | 2.02 | 0.67 | 1.23 | 0.18 | 1.79 | 0.70 | 1.12 | 0.62 |
| 2-Hydroxyglutarate/Citramalate | ME934323 | 1.06 | 1.65 | 0.87 | 0.15 | 1.32 | 1.58 | 1.59 | 0.66 | 0.11 |
| alpha-D-Ribose 1-phosphate | ME934327 | 1.50 | 1.10 | 1.34 | 0.40 | 1.01 | 1.03 | 1.23 | 0.95 | 0.45 |
| 2-Oxoglutarate | ME934319 | 1.27 | 1.23 | 0.83 | 0.13 | 2.26 | 0.74 | 1.76 | 0.34 | 0.15 |
| 2-Oxoglutarate 13C5 | ME934364 | NA | 1.01 | NA | 0.55 | NA | 1.01 | NA | 1.31 | 1.12 |
| 2-Oxoglutarate 13C3 | ME934363 | NA | 1.29 | NA | 0.83 | NA | 0.83 | NA | 0.80 | 1.26 |
| 5-6-Dihydrothymine | ME934302 | 1.10 | 0.55 | 0.89 | 1.33 | 1.01 | 0.92 | 0.98 | 1.02 | 1.19 |
| 5-6-Dihydrouracil | ME934341 | 1.28 | 0.80 | 0.92 | 1.03 | 0.87 | 0.98 | 1.23 | 0.96 | 1.02 |
| 2/3-Phospho-D-glycerate | ME934311 | 0.64 | 1.10 | 0.57 | 0.27 | 0.83 | 1.94 | 0.81 | 2.30 | 0.52 |
| alpha-D-Glucosamine 1-phosphate | ME934336 | 1.30 | 0.90 | 1.16 | 0.60 | 1.32 | 1.18 | 1.08 | 1.17 | 0.29 |
| 6-Phospho-D-gluconate | ME934324 | NA | 0.75 | 0.42 | 1.12 | 0.79 | 0.99 | 1.32 | 1.43 | 0.96 |
| ADP-D-ribose | ME934305 | 0.78 | 0.80 | 0.35 | 0.70 | 0.99 | 1.52 | 1.78 | 1.25 | 0.82 |
| 3-Phosphonooxypyruvate | ME934332 | 1.10 | 0.95 | 0.98 | 0.53 | 1.06 | 1.06 | 1.41 | 1.14 | 0.78 |
| ADP 13C2 | ME934377 | NA | 1.20 | NA | 1.03 | NA | 1.00 | NA | 0.92 | 0.86 |
Factors:
| F1 | Timepoint (h):18 | LPS treatment (ng/ml):0 | E coli viability:dead | Multiplicity of infection:25 | well vs insert source:NA |
| F2 | Timepoint (h):18 | LPS treatment (ng/ml):0 | E coli viability:dead | Multiplicity of infection:50 | well vs insert source:well |
| F3 | Timepoint (h):18 | LPS treatment (ng/ml):0 | E coli viability:live | Multiplicity of infection:25 | well vs insert source:NA |
| F4 | Timepoint (h):18 | LPS treatment (ng/ml):0 | E coli viability:NA | Multiplicity of infection:NA | well vs insert source:insert |
| F5 | Timepoint (h):18 | LPS treatment (ng/ml):0 | E coli viability:NA | Multiplicity of infection:NA | well vs insert source:NA |
| F6 | Timepoint (h):18 | LPS treatment (ng/ml):0 | E coli viability:NA | Multiplicity of infection:NA | well vs insert source:well |
| F7 | Timepoint (h):18 | LPS treatment (ng/ml):500 | E coli viability:NA | Multiplicity of infection:NA | well vs insert source:NA |
| F8 | Timepoint (h):6 | LPS treatment (ng/ml):0 | E coli viability:dead | Multiplicity of infection:50 | well vs insert source:well |
| F9 | Timepoint (h):6 | LPS treatment (ng/ml):0 | E coli viability:NA | Multiplicity of infection:NA | well vs insert source:insert |
